Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Crawford

Orthopaedic Surgery of the Spine Louisville, KY Medical Doctor

NPI 1265570808 CMS profile 103193

210 E Gray St, Suite 900, Louisville, KY 40202

Open in the dashboard

General payments

$836,096

371 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$19,596

2 holdings reported · through program year 2025

Through program year 2025, Charles Crawford of Louisville, KY is reported in the CMS Open Payments database as having received $836,096 across 371 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $19,596 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $241,205 93
2024 General $170,135 61
2023 General $149,757 69
2022 General $78,715 32
2021 General $91,791 38
2020 General $47,022 38
2019 General $57,472 40
2025 Ownership $18,897 1
2024 Ownership $699 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Crawford
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Charles Crawford were reported at $241,205. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Charles Crawford Orthopaedic Surgery of the Spine median Middle half National median
2019 $57,472 $2,106 $337–$18,608 $163
2020 $47,022 $1,213 $156–$15,082 $114
2021 $91,791 $1,834 $271–$15,617 $132
2022 $78,715 $2,015 $320–$17,036 $149
2023 $149,757 $1,925 $336–$14,599 $160
2024 $170,135 $2,110 $341–$12,483 $164
2025 $241,205 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $375,978 197 payments
  2. NuVasive, Inc. $179,184 54 payments
  3. Globus Medical, Inc. $143,802 29 payments
  4. Alphatec Spine, Inc $59,304 7 payments
  5. Medtronic USA, Inc. $54,175 63 payments
  6. Exapnding Innovations, Inc. $19,054 4 payments
  7. SI-BONE, Inc. $3,621 9 payments
  8. Stryker Corporation $436 3 payments
  9. Ebi, LLC $146 1 payment
  10. Medacta USA, Inc. $125 1 payment
  11. Other $272 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $542,398 38 payments
  2. Consulting Fee $192,186 102 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,300 13 payments
  4. Travel and Lodging $34,476 79 payments
  5. Food and Beverage $9,737 139 payments
Products named General payments · program years 2019–2025
  1. Modulus Spine/Spine Surgery $247,160 17 payments
  2. Arsenal Deformity $59,194 6 payments
  3. INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM $36,638 27 payments
  4. CD HORIZON $35,537 38 payments
  5. Modulus Spine $32,895 3 payments
  6. Arsenal Degen $31,569 1 payment
  7. ALIF $31,348 14 payments
  8. Arsenal Degenerative $27,539 4 payments
  9. CD HORIZON SPINAL SYSTEM $25,308 31 payments
  10. INFUSE BONE GRAFT $21,489 20 payments
  11. Other $113,682 140 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

172

Median for Orthopedic Surgery: 203

Drug cost

$1,585

Median for Orthopedic Surgery: $1,433

Branded share of claims

51.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 54 $707
Gabapentin Generic 46 $368
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 35 $321
Baclofen Generic 20 $111
Tizanidine Hcl Generic 17 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$279,972

Medicare's payments for the services billed

Medicare patients

282

Average age 72

Services billed

1,198

144 women, 138 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 30%
Depression 29%
Osteoporosis 23%
COPD 22%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

371 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record